Related Experiment Video
Updated: Feb 6, 2026

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
8p11 Myeloproliferative syndrome with t(8;22)(p11;q11): A case report
1Department of Hematology, Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Abstract:
The 8p11 myeloproliferative syndrome (EMS), a rare myeloproliferative disease, generally progresses rapidly and is characterized by chromosomal translocations of the fibroblast growth factor receptor 1 (FGFR1) gene. The FGFR1 gene is located at chromosome 8p11 and may fuse with distinct partner genes. The breakpoint cluster region gene located at chromosome 22 is one of these partner genes. The patients' clinical phenotype is primarily dependant on the partner gene that translocates with FGFR1. Of all the available examinations, determination of the chromosome karyotype is most essential for the diagnosis of EMS. In addition, regarding treatment, allogeneic hematopoietic stem cell transplantation is currently the optimal method. The present study presented a case of 8p11 myeloproliferative syndrome with t(8;22)(p11;q11). This represents a total of 8 and 11 chromosomal translocations, which form a BCR/FGFR1 fusion gene in the patient to produce the abnormal karyotype: 46,XY,t(8;22)(p11;q11). The difference between the current case and other EMS incidences is that the patient progressed slowly and the clinical manifestation was similar to chronic myeloid leukemia (CML).
Insights
8p11 myeloproliferative syndrome (EMS) involves FGFR1 gene translocations. A rare case with a BCR/FGFR1 fusion gene presented with slow progression, mimicking chronic myeloid leukemia (CML).
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- 8p11 myeloproliferative syndrome (EMS) is a rare, aggressive hematologic disorder.
- It is characterized by chromosomal translocations involving the fibroblast growth factor receptor 1 (FGFR1) gene at chromosome 8p11.
- The clinical presentation of EMS is influenced by the specific partner gene fused with FGFR1.
Purpose of the Study:
- To present a unique case of 8p11 myeloproliferative syndrome (EMS).
- To highlight the diagnostic and clinical features of a specific BCR/FGFR1 fusion gene.
- To discuss the atypical slow progression observed in this EMS case.
Main Methods:
- Karyotype analysis to determine chromosomal abnormalities.
- Identification of the specific translocation t(8;22)(p11;q11).
- Molecular analysis to confirm the BCR/FGFR1 fusion gene.
Main Results:
- A case of EMS with the karyotype 46,XY,t(8;22)(p11;q11) was identified.
- The translocation resulted in the formation of a BCR/FGFR1 fusion gene.
- The patient exhibited a slow disease progression, clinically resembling chronic myeloid leukemia (CML).
Conclusions:
- The diagnosis of EMS relies heavily on chromosome karyotype determination.
- Allogeneic hematopoietic stem cell transplantation remains the optimal treatment for EMS.
- This case underscores the variability in EMS clinical presentation and progression.
Related Concept Videos
Data Reporting and Recording
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Nephrotic Syndrome I : Introduction
Types of Reports III: Telephone and Verbal Reports
Here's an overview of each type:
Telephone Orders
Reporter Genes

